Michael Naso Email

SVP, Cell Engineering . Century Therapeutics

Philadelphia, PA

Location

m****@centurytx.com

Primary Email

LinkedIn

Current Roles

Employees:
281
Revenue:
$35.2M
About
Our genetically-engineered, universal iPSCs-derived immune effector cell products (NK, T, Dendritic cells, and macrophage) are designed to specifically target hematologic and solid tumor cancers. Our commitment to developing off-the-shelf cell therapies will expand patient access and provides an unparalleled opportunity to advance the course of cancer care.
Century Therapeutics Address
25 N. 38th Street
Philadelphia, PA
United States

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.